Glomerulonephritis Overview

Save information for later
Sign Up

Learn About Glomerulonephritis

What is the definition of Glomerulonephritis?
Glomerulonephritis is a type of kidney disease in which there is inflammation of the glomeruli, the tiny filters that remove excess waste and fluids from the blood. It may be acute or chronic (coming on gradually), and may occur on its own (primary) or be caused by another condition (secondary). Signs and symptoms may depend on the type and cause of the condition and may include blood in the urine; foamy urine; swelling of the face, eyes, or other body parts; abdominal pain; high blood pressure; fatigue; and/or other symptoms. If the condition is severe or prolonged, the kidneys can become damaged. It may be caused by a variety of infections and diseases, and sometimes the cause is unknown.
What are the alternative names for Glomerulonephritis?
  • Glomerulonephritis
  • Bright's disease
Who are the top Glomerulonephritis Local Doctors?
Dr. Renu Regunathan-Shenk
Nephrology
Dr. Renu Regunathan-Shenk
Nephrology

Virginia Nephrology Group Llp

3930 Walnut St, Suite 101, 
Fairfax, VA 
 19.3 mi
Accepting New Patients
Offers Telehealth
Languages Spoken English

Renu Regunathan-Shenk is a Nephrologist in Fairfax, Virginia. Dr. Regunathan-Shenk has been practicing medicine for over 14 years and is rated as an Advanced provider by MediFind in the treatment of Glomerulonephritis. Her top areas of expertise are Glomerulonephritis, Chronic Kidney Disease, End-Stage Renal Disease (ESRD), and Nephrotic Syndrome. Dr. Regunathan-Shenk is currently accepting new patients.

Dr. Amar S. Kapur
Family Medicine
Dr. Amar S. Kapur
Family Medicine

Inova Physician Partners LLC

3914 Centreville Rd, Suite 250, 
Chantilly, VA 
 12.6 mi
Accepting New Patients
Offers Telehealth
Languages Spoken English

Amar Kapur is a Family Medicine provider in Chantilly, Virginia. Dr. Kapur and is rated as an Experienced provider by MediFind in the treatment of Glomerulonephritis. His top areas of expertise are Glomerulonephritis and Common Cold. Dr. Kapur is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Dr. Ali R. Assefi
Nephrology
Dr. Ali R. Assefi
Nephrology

Nephrology Associates Of Northern Virginia Inc

46396 Benedict Dr, Suite 220, 
Sterling, VA 
 13.7 mi
Accepting New Patients
Offers Telehealth
Languages Spoken English

Ali Assefi is a Nephrologist in Sterling, Virginia. Dr. Assefi and is rated as an Experienced provider by MediFind in the treatment of Glomerulonephritis. His top areas of expertise are Acute Kidney Failure, End-Stage Renal Disease (ESRD), Chronic Kidney Disease, and Nephrosclerosis. Dr. Assefi is currently accepting new patients.

View All Doctors
What are the latest Glomerulonephritis Clinical Trials?
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
Who is this study for: Patients with Nephrotic Syndrome, Proteinuria, Autoimmune Disease
Enrollment Status: Recruiting
Publish Date: January 15, 2025
Intervention Type: Drug
Study Drugs: Rituximab Infusion, Oral Cyclosporine
Study Phase: Phase 2

Background: * Membranous nephropathy is associated with damage to the walls of the glomeruli, the small blood vessels in the kidneys that filter waste products from the blood. This damage causes leakage of blood proteins into the urine and is associated with low blood protein levels, high blood cholesterol values, and swelling of the legs. These problems can decrease or go away without treatment in about 25 p...

Match to trials
Find the right clinical trials for you in under a minute
Get started
The CALiPSO-1 Study: A Study of CNTY-101, a CD19-targeted CAR iNK Cell Product, in Participants With Refractory B Cell-mediated Autoimmune Diseases
The CALiPSO-1 Study: A Study of CNTY-101, a CD19-targeted CAR iNK Cell Product, in Participants With Refractory B Cell-mediated Autoimmune Diseases
Enrollment Status: Recruiting
Publish Date: January 15, 2025
Intervention Type: Drug, Biological
Study Phase: Phase 1

Summary: CALiPSO-1 is a Phase 1, multi-centre, dose-confirmation study to evaluate the safety and efficacy of CNTY-101 in participants with refractory B cell-mediated autoimmune diseases including those with moderate to severe systemic lupus erythematosus (SLE)/ lupus nephritis (LN), idiopathic inflammatory myopathies (IIM), and diffuse cutaneous systemic sclerosis (DcSSc).

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center